FREDUN PHARMACEUTICALS LIMITED Fredun Pharmaceuticals Limited reported earnings results for the full year ended March 31, 2024. For the full year, the company reported sales was INR 3,465.77 million compared to INR 2,743.42 million a year ago. Revenue was INR 3,490.72 million compared to INR 2,764.98 million a year ago.
Net income was INR 156.23 million compared to INR 108.07 million a year ago. Basic earnings per share from continuing operations was INR 33.66 compared to INR 24.13 a year ago. Diluted earnings per share from continuing operations was INR 33.66 compared to INR 24.13 a year ago.
